Antibacterial Drugs Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

Antibacterial Drugs Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

Antibacterial drugs are used in treatment or prohibition of bacterial infections caused due to various factors such as climatic changes, unhygienic lifestyle specially in emerging economies and others. Major challenge associated with antibacterial drugs is resistance of bacteria towards it. Significant studies are carried out to develop new antibacterial drugs to combat these problems.

Market Dynamics

Increasing prevalence of infectious diseases is a major factor driving antibacterial drugs market growth. According to World Health Organization (WHO), September 2018, annually around 11 million to 21 million cases of typhoid fever are reported worldwide. Moreover, growing geriatric population susceptible to high risk of bacterial infection, majorly caused due to age related changes in immunology is expected to boost the market growth. The Current Opinion in Microbiology Journal 2016, stated Lower respiratory tract infection (Pneumonia), as the most common cause of infection disease in older patients in the U.S. and estimated it as 6 leading cause of death in the U.S.

However, price control of antibacterial drugs, genetic mutation in aging population, and decrease in financial incentives has distracted the focus of pharmaceutical companies from research and development of antibacterial drugs. In September 2016, AstraZeneca announced an agreement with Pfizer to sell the development and commercialization rights to its late-stage small molecule antibiotics business as AstaZeneca does not find antibiotic research as major area for development in their business

Key features of the study:

  • This report provides in-depth analysis of the antibacterial drugs market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017, as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global antibacterial drugs market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Novartis AG, Allergan, Bristol Myers Squibb Company, AstraZeneca, Johnson and Johnson, Merck & Co., Inc., GlaxoSmithKline Plc. (GSK), Sanofi, Bayer AG, and Pfizer Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
  • The global antibacterial drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the antibacterial drugs market
Detailed Segmentation:
  • Global Antibacterial Drugs Market, By Drug class:
  • Beta lactams
  • Quinolones Macrolides
  • Tetracycline
  • Aminoglycoside
  • Sulfonamide
  • Phenicols
  • Others
  • Global Antibacterial Drugs Market, By Route of Administration:
  • Oral
  • Topical
  • Parenteral
  • Others
  • Global Antibacterial Drugs Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Antibacterial Drugs Market, By Geography:
  • North America
  • By Drug Class:
  • Beta lactams
  • Quinolones Macrolides
  • Tetracycline
  • Aminoglycoside
  • Sulfonamide
  • Phenicols
  • Others
  • By Route of Administration:
  • Oral
  • Topical
  • Parenteral
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • U.S.
  • Canada
  • Latin America
  • By Drug Class:
  • Beta lactams
  • Quinolones Macrolides
  • Tetracycline
  • Aminoglycoside
  • Sulfonamide
  • Phenicols
  • Others
  • By Route of Administration:
  • Oral
  • Topical
  • Parenteral
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Drug Class:
  • Beta lactams
  • Quinolones Macrolides
  • Tetracycline
  • Aminoglycoside
  • Sulfonamide
  • Phenicols
  • Others
  • By Route of Administration:
  • Oral
  • Topical
  • Parenteral
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Drug Class:
  • Beta lactams
  • Quinolones Macrolides
  • Tetracycline
  • Aminoglycoside
  • Sulfonamide
  • Phenicols
  • Others
  • By Route of Administration:
  • Oral
  • Topical
  • Parenteral
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Drug Class:
  • Beta lactams
  • Quinolones Macrolides
  • Tetracycline
  • Aminoglycoside
  • Sulfonamide
  • Phenicols
  • Others
  • By Route of Administration:
  • Oral
  • Topical
  • Parenteral
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Drug Class:
  • Beta lactams
  • Quinolones Macrolides
  • Tetracycline
  • Aminoglycoside
  • Sulfonamide
  • Phenicols
  • Others
  • By Route of Administration:
  • Oral
  • Topical
  • Parenteral
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Novartis AG *
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Highlights
  • Market Strategies
  • Allergan
  • Bristol Myers Squibb Company
  • AstraZeneca
  • Johnson and Johnson
  • Merck & Co., Inc.
  • GlaxoSmithKline Plc.
  • Sanofi SA
  • Bayer AG
  • Pfizer Inc.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Class
Market Snippet, By Route of Administration
Market Snippet, By Distribution channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Pipeline Analysis
Reimbursement Scenario
Epidemiology
Pest Analysis
Regulatory Scenario
New Product Launches
Collaborations and Agreements
Market Trends
4. Global Antibacterial Drugs Market, By Drug Class, 2018 – 2026 (US$ Mn)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Beta lactams
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
Quinolones
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
Macrolides
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
Tetracyclines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
Aminoglycosides
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
Sulphonamides
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
Phenicols
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
5. Global Antibacterial Drugs Market, By Route of Administration, 2018 – 2026 (US$ Mn)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
Topical
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
Parenteral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
6. Global Antibacterial drugs Market, By Distribution Channel, 2018 – 2026 (US$ Mn)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026 (US$ Mn)
7. Global Antibacterial Drugs Market, By Region, 2018 – 2026 (US$ Mn)
Introduction
Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2026
North America
Market Size and Forecast, By Drug Class, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
U.S.
Canada
Latin America
Market Size and Forecast, By Drug Class, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Market Size and Forecast, By Drug Class, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Drug Class, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of APAC
Middle East
Market Size and Forecast, By Drug Class, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Drug Class, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
South Africa
Central Africa
North Africa
8. Competitive Landscape
Heat Map Analysis
Company Profiles
Novartis AG
Company Overview
Product Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Allergan
Company Overview
Product Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Bristol Myers Squibb Company
Company Overview
Product Type Portfolio
Financial Overview
Key Highlights
Market Strategies
AstraZeneca
Company Overview
Product Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Johnson and Johnson
Company Overview
Product Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Merck & Co., Inc.
Company Overview
Product Type Portfolio
Financial Overview
Key Highlights
Market Strategies
GlaxoSmithKline Plc.
Company Overview
Product Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Sanofi SA
Overview
Product Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Bayer AG
Company Overview
Product Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Pfizer Inc.
Company Overview
Product Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Analyst Views
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 25 market data tables and 27 figures on "Antibacterial Drugs Market - Global forecast to 2026”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook